Memorial Sloan Kettering medical oncologist Michael Offin

Michael D. Offin, MD

Thoracic Medical Oncologist

Areas of Expertise

Conditions I Treat

  • Mesothelioma
  • Lung cancer

My Specialties

  • Targeted therapy
  • Clinical trials
View all expertise
Dr. Offin's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Back to top
English
Share

Get to Know Me

I am a board-certified medical oncologist dedicated to caring for people with mesothelioma and lung cancer.

Finding out that you or a family member has a thoracic cancer can be overwhelming. My team and I will help you understand your diagnosis and find the best path forward. I am devoted to providing the highest level of care throughout my patient’s treatment with the goal of providing a personalized approach to improve outcomes and quality of life.

Read more

I care for people with lung cancers (including those patients whose tumors harbor a BRAF alteration) and mesotheliomas (including pleural and peritoneal disease) at the David H. Koch Center for Cancer Care at MSK in Manhattan. As the co-director of the MSK Mesothelioma Program, I work with a comprehensive team of cancer experts from various disciplines to ensure that all of my patients receive individualized and exceptional care.

My research focuses on using laboratory findings to design clinical trials that further the care of my patients. With precision medicine and immunotherapy, people with thoracic cancers, including those with advanced disease, may have several treatment and clinical trial options available. Through my research, and when caring for my patients, I endeavor to analyze available options with a constant eye on evaluating new treatments. I aim to bring the discoveries made by our laboratory researchers to the bedside for the benefit of my patients and beyond. 

What I Do at MSK

I'm a thoracic medical oncologist, which is a cancer doctor who specializes in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.

  • Co-Director, Mesothelioma Program
  • Assistant Attending Physician
Areas of Expertise

Conditions I Treat

  • Mesothelioma
  • Lung cancer

My Specialties

  • Targeted therapy
  • Clinical trials
Education & Honors

Education

  • MD, Rutgers University- New Jersey Medical School

Residencies

  • Internal Medicine – Hospital of the University of Pennsylvania

Fellowships

  • Medical Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

  • Internal Medicine
  • Medical Oncology

Awards and Honors

  • Career Development Award, LUNGevity
  • Young Investigator Award, International Mesothelioma Interest Group
  • Deans Award, Rutgers University
  • Alpha Omega Alpha Member
  • Gold Humanism Honor Society Member
  • Conquer Cancer Foundation ASCO Merit Award (2018)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9163— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”

Contact and Location

Dr. Offin sees patients at one location.

Office Phone
Location
New York, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Clinical Trials

Read more
Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Offin M, Yang SR, Egger J, Jayakumaran G, Spencer RS, Lopardo J, Nash GM, Cercek A, Travis WD, Kris MG, Ladanyi M, Sauter JL, Zauderer MG. Molecular Characterization of Peritoneal Mesotheliomas. J Thorac Oncol. 2022 Mar;17(3):455-460. doi: 10.1016/j.jtho.2021.09.012. Epub 2021 Oct 11. PMID: 34648949; PMCID: PMC8882128.

Offin M, Sauter JL, Tischfield SE, Egger JV, Chavan S, Shah NS, Manoj P, Ventura K, Allaj V, de Stanchina E, Travis W, Ladanyi M, Rimner A, Rusch VW, Adusumilli PS, Poirier JT, Zauderer MG, Rudin CM, Sen T. Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library. Genome Med. 2022 Nov 15;14(1):127. doi: 10.1186/s13073-022-01129-4. PMID: 36380343; PMCID: PMC9667652.

Offin M, De Silva DL, Sauter JL, Egger JV, Yorke E, Adusumilli PS, Rimner A, Rusch VW, Zauderer MG. Multimodality Therapy in Patients With Primary Pericardial Mesothelioma. J Thorac Oncol. 2022 Dec;17(12):1428-1432. doi: 10.1016/j.jtho.2022.08.017. Epub 2022 Sep 6. PMID: 36075530; PMCID: PMC9691618.

Read more

Murciano-Goroff YR, Pak T, Mondaca S, Flynn JR, Montecalvo J, Rekhtman N, Halpenny D, Plodkowski AJ, Wu SL, Kris MG, Paik PK, Riely GJ, Yu HA, Rudin CM, Hellmann MD, Land JD, Buie LW, Heller G, Lito P, Yaeger R, Drilon A, Liu D, Li BT, Offin M. Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers. Br J Cancer. 2022 Apr;126(6):889-898. doi: 10.1038/s41416-021-01679-1. Epub 2021 Dec 28. PMID: 34963703; PMCID: PMC8927094.

Publications on PubMed

Visit PubMed for a full listing of Dr. Offin’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Michael D. Offin discloses the following relationships and financial interests:

  • Mesothelioma Applied Research Foundation
    Professional Services and Activities (Uncompensated)
  • MJH Life Sciences
    Professional Services and Activities
  • Pfizer, Inc.
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: